ArticleTherapeutic advances in chronic disease2022

A randomized, controlled trial on fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid.

Chunlei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.